AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2013

Jul 23, 2013

31580_dirs_2013-07-23_e0f85214-13f7-40f3-9409-58e0f1123bd0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2013-07-23

Reporting Person: Cantley Lewis Clayton Jr. (Director, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	363636	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.47	2020-08-11	Common Stock (90909)		Direct
Stock Option (Right to Buy)	$0.47	2020-08-11	Common Stock (54545)		Direct

Footnotes

F1: Reflects a 1-for-2.75 reverse stock split effected on July 11, 2013.

F2: This option was granted on August 12, 2010. The shares underlying this option vest as to 25% of the shares on July 15, 2011, with the remaining 75% vesting in 36 equal monthly installments thereafter.

F3: This option was granted on August 12, 2010 and is fully vested.